| Trial ID: | L6672 |
| Source ID: | NCT01302028
|
| Associated Drug: |
Asp1941
|
| Title: |
Renal Impairment Study With ASP1941
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: ASP1941
|
| Outcome Measures: |
Primary: Effect of grade of renal impairment on the pharmacokinetics of ASP1941, 5 days | Secondary: Effect of grade of renal impairment on the pharmacodynamics of ASP1941, 5 days|Assessment of safety through evaluation of adverse events, physical examination, vital sins, lab-tests and 12-lead ECG, 5 days
|
| Sponsor/Collaborators: |
Sponsor: Astellas Pharma Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-01-22
|
| Completion Date: |
2010-06-26
|
| Results First Posted: |
|
| Last Update Posted: |
2017-08-22
|
| Locations: |
Brno, 62500, Czechia|Prague, 16900, Czechia|Balatonfured, 8230, Hungary|Warsaw, 02-097, Poland|Bratislava, 83305, Slovakia
|
| URL: |
https://clinicaltrials.gov/show/NCT01302028
|
